BiondVax Pharmaceuticals Earning Date (BVXV)

USA |NASDAQ |USD

BVXV Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 26, 2022 (est) Jun 30, 2022 $-0.10 $-0.20 $-0.25
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 26, 2022 (est) Jun 30, 2022 $0.00 $0.00 $0.00

Biondvax Pharmaceuticals's next estimated earnings date (based on same quarter last year's date) is Aug 26, 2022 for the fiscal quarter ending Jun 30, 2022.

BVXV Earnings Date & History Chart

BVXV Earnings & Revenue Forecast

BVXV Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Sep 2022 2 $-0.11 $-0.21 $-0.01
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 2 $-0.41 $-0.81 $-0.02
Dec 2023 2 $-0.45 $-0.89 $-0.02

BVXV Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Sep 2022 0 / 0 $-0.11 $-0.17 $-0.17
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-0.41 $-0.35 $-0.35
Dec 2023 1 / 0 $-0.45 $-0.38 $-0.38

BVXV Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Sep 2022 2 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 2 $0.00 $0.00 $0.00
Dec 2023 2 $0.00 $0.00 $0.00

BVXV Earnings Date & Revenue History

BVXV Earnings History

|
Show More
Show More

BVXV Revenue History

|
Show More
Show More

Biondvax Pharmaceuticals Next Earnings Date & Report

BVXV Jun 2022 (FQ) Earnings Date & Report Preview

BVXV's next estimated earnings date (based on same quarter last year's report date) is Aug 26, 2022 for the fiscal quarter ending Jun 30, 2022.

Biondvax Pharmaceuticals Previous Earnings Dates & Reports

BVXV Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Biondvax Pharmaceuticals's previous earnings date was Jun 1, 2022 for its fiscal quarter ended Mar 31, 2022.

BVXV's earnings per share (EPS) was $-0.20, missing the consensus analysts forecast of $-0.10 by -100.00%.

The EPS was higher than the previous fiscal quarter (Dec 2021) by -25.93%, and higher than the same period a year before (Mar 2021) by -22.09%.

Revenues were $0.00.

The company reported a net income of $-9.42M.

BVXV ended the quarter with $71.57M in total debt, an increase of 2.63% compared to the previous quarter, and an increase of 3.78% compared to the same quarter a year before.

BVXV Previous Earnings Date & Report Recap: Dec 2021 (FY)

Biondvax Pharmaceuticals's previous annual earnings date was Mar 28, 2022 for its fiscal year ended Dec 31, 2021.

BVXV's earnings per share (EPS) was $-0.97.

Revenues were $0.00.

The company reported a net income of $-39.98M.

Biondvax Pharmaceuticals reported a free cash flow of $-24.91M for its fiscal year, compared to $-78.67M a year ago.

The company ended the fiscal year with $69.74M in total debt, an increase of 3.83% compared to the previous year.